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aurrent American College of Cardiology/American Heart
ssociation (ACC/AHA) guidelines recommend a goal
eperfusion time of 90 min or less between medical contact
nd first intracoronary balloon inflation (i.e., door-to-
alloon [DTB] time) in patients with ST-segment elevation
yocardial infarction (STEMI) undergoing primary percu-
aneous coronary intervention (PCI) (1). On the basis of
hese recommendations, several government agencies and
ealth care groups, including the Centers for Medicare and
edicaid Services and the Joint Commission on Accredi-
ation of Healthcare Organizations, now expect clinicians
nd hospitals to meet these recommended performance
tandards and have designated DTB time as a reportable
ore Measure (2).
Given the intense focus placed on hospitals and health
are providers to meet the DTB time Core Measure, various
trategies such as public reporting of individual hospital
dherence to performance measurements, designations of
enters of Excellence, and Pay-for-Performance initiatives
ave been designed to further motivate hospitals and health
are providers to focus efforts on resources aimed to achieve
he recommended DTB time of90 min, with the ultimate
oal of improving clinical outcomes.
rom the *University of Colorado Denver, Aurora, Colorado; †Duke Clinical
esearch Institute, Durham, North Carolina; and the ‡Denver VA Medical Center,
enver, Colorado.p
Manuscript received May 14, 2008; revised manuscript received July 24, 2008,
ccepted August 4, 2008.In clinical practice, however, a variety of challenges can
ontribute to delays in therapy, leading to a sizeable proportion
f patients with STEMI not being treated within the recom-
ended ACC/AHA goal DTB time frame (3). One potential
eason for delay in DTB time is the presence of previous
oronary artery bypass grafting (CABG) in the patient, which
equires visualization before percutaneous intervention. Be-
ause the DTB time Core Measure is neither risk-adjusted nor
tratified by a history of previous CABG surgery, it is possible
hat hospitals treating an above-average proportion of patients
ith previous CABG surgery would report inherently poorer
erformance. The association between previous CABG sur-
ery and DTB time, however, has to our knowledge never been
horoughly investigated.
Given the potentially detrimental impact of prolonged
TB time on both clinical outcomes (4–6) as well as public
eporting of hospital performance, we queried the National
ardiovascular Data Registry (NCDR) to determine
hether a previous history of CABG surgery correlates with
rolonged DTB times among STEMI patients undergoing
rimary PCI. We further investigated whether this unique
roup of patients experiences a higher incidence of in-
ospital mortality when compared with patients without
revious CABG surgery.
ethods
ata collection. The NCDR is a national registry of
atients undergoing diagnostic cardiac catheterizations
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Association of Previous CABG Surgery With DTB Time November 11, 2008:1665–70and/or PCI (7). The registry in-
cludes a standardized set of data
elements and definitions, sys-
tematic data entry and transmis-
sion procedures, and rigorous
data quality assurance standards.
Data are thoroughly screened
upon receipt, and only data
meeting pre-determined criteria
for completeness and accuracy
are entered into the NCDR. Our
study used version 3.0 of the
CathPCI Registry, which repre-
sents patients entered into the
NCDR between January 1, 2004,
and March 30, 2007.
Study population. We analyzed
data submitted to the NCDR
rom 727,260 cardiac catheterization laboratory visits at 638
nstitutions. From these data, we identified 93,330 patients
12.8%) who underwent primary PCI for STEMI. Of these,
e further identified and excluded 16,164 patients (17.3%)
ho underwent either rescue or facilitated PCI for STEMI.
urthermore, 3,954 patients (5.1%) with a reported DTB
ime either 720 min or 0 min (i.e., not reported) were
xcluded. Our study population consisted of the remaining
atients (n  73,212) who underwent primary PCI for
TEMI and was divided into patients with and without a
revious history of CABG surgery.
The DTB time and in-hospital mortality were analyzed
or each study group. In addition, the interaction between a
revious history of CABG surgery and DTB time was
valuated. Finally, to account for DTB time delays related
o patient transfer from a referring facility, each group was
urther subdivided into patients that were either transferred
rom a referring facility for primary PCI or had primary PCI
erformed at the same facility as initial presentation.
ata definitions. The DTB time was defined as the time
rom emergency department arrival at the transferring
acility (for patients transferred from a referring facility) or
ospital arrival at the facility performing primary PCI (for
atients not transferred from a referring facility) until
eployment of the first intracoronary treatment device. In
atients who underwent PCI of multiple lesions during
heir initial cardiac catheterization procedure, the first lesion
reated was considered to be the culprit lesion, and the
haracteristics of the designated culprit lesion were recorded
nd analyzed.
tatistical analysis. Categorical variables were compared
ith the Pearson chi-square test. Continuous variables were
resented as medians (25th, 75th percentiles) and were
ompared with the use of Wilcoxon rank sum tests. The
elationships between predictor variables and mortality were
nalyzed with logistic generalized estimating equation mod-
ls. Variables entered into the generalized estimating equa-
Abbreviations
and Acronyms
ACC/AHA  American
College of Cardiology/
American Heart Association
CABG  coronary artery
bypass graft
CI  confidence interval
DTB  door-to-balloon
NCDR  National
Cardiovascular Data Registry
OR  odds ratio
PCI  percutaneous coronary
intervention
STEMI  ST-segment
elevation myocardial
infarctionion model included age, cardiogenic shock at admission, trevious congestive heart failure, previous valve surgery,
erebrovascular disease, peripheral vascular disease, chronic
ung disease, previous PCI, pre-operative intra-aortic bal-
oon pump, ejection fraction, lesion 50%, pre-procedure
hrombolysis In Myocardial Infarction (TIMI) flow grade
, diabetes, high-risk lesion (class C), body mass index,
lomerular filtration rate, New York Heart Association
unctional class IV, lesion location, and PCI status (urgent,
mergency, salvage).
esults
atient characteristics. During the study period, 4,211
5.8%) patients undergoing primary PCI for STEMI had a
revious history of CABG surgery. Baseline patient char-
cteristics are shown in Table 1. Patients with previous
ABG surgery were older, men, and more likely to have
iabetes, hypertension, dyslipidemia, chronic kidney dis-
ase, and a previous history of myocardial infarction, PCI,
erebrovascular disease, peripheral vascular disease, or con-
estive heart failure.
rocedural characteristics. Procedural details between
tudy groups are shown in Table 2. Patients with previous
ABG surgery required significantly longer fluoroscopy
imes and greater contrast volumes. Although there was no
ignificant difference in lesion length between study groups,
atients with previous CABG surgery demonstrated a
ignificantly greater frequency of high risk (i.e., ACC/AHA
ype C) lesions. Finally, patients with previous CABG
urgery had significantly lower post-procedure peak tropo-
in and creatine kinase-MB values compared with patients
ithout previous CABG surgery.
ssociation of previous CABG with DTB time. Median
TB time was significantly longer in patients with previous
ABG surgery (113 min vs. 98 min; p  0.0001). The
istribution of DTB time between the study groups was
tatistically different, with an overall larger percentage of
atients with previous CABG surgery having a DTB time
90 min (68.4% vs. 56.7%; p  0.0001) (Fig. 1). Among
atients with previous CABG, there was no significant differ-
nce in median DTB time between those with a culprit lesion
n a native versus graft vessel (111 min vs. 113 min; p 0.11).
urthermore, among patients with previous CABG, the
ercentage of patients achieving a DTB time 90 min was
imilar across groups (32% of the native vessel culprit group
s. 31% of the graft vessel culprit group; p  0.28).
Median DTB times were longer in patients with a
revious CABG, regardless of whether patients underwent
rimary PCI at the presenting facility (99 min vs. 84 min;
 0.0001) or were transferred from a referring hospital
187 min vs. 158 min; p  0.0001). In addition, a subgroup
nalysis based on need for patient transport revealed that
ite of presentation influenced DTB time. As shown in
igure 2, among patients with and without a previous
ABG surgery who underwent primary PCI at the presen-ation facility, the greatest proportion of patients (40% and
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November 11, 2008:1665–70 Association of Previous CABG Surgery With DTB Time6.6%, respectively) had a DTB time 90 min. In patients
ith and without previous CABG surgery who were trans-
erred to a second facility for primary PCI, the greatest
roportion of patients (84.1% and 74.4%, respectively) had
DTB time 120 min.
Among the 3,954 patients with reported DTB time
720 min or 0 min, 3,059 patients had a DTB time of
720 min, among which 239 patients had a history of
revious CABG surgery. Among excluded patients, median
TB times were significantly longer in patients with pre-
ious CABG surgery (1,662 min vs. 1,436 min; p 
.0001). In addition, when excluded patients were subdi-
ided based on their need for transfer to a facility perform-
ng primary PCI, patients with previous CABG demon-
trated significantly longer DTB times if they underwent
rimary PCI at the presenting facility (1,686 min vs. 1,384
in; p  0.0001) and demonstrated a trend toward signif-
Table 1 Baseline Patient Characteristics
Previous CAB
Yes (n  4,2
Age, yrs (mean) 66.0
Cardiogenic shock 11.3%
Congestive heart failure 13.5%
Previous valve surgery 2.9%
Cerebrovascular disease 13.9%
Peripheral vascular disease 17.3%
Chronic lung disease 16.7%
Previous PCI 41.3%
Pre-operative IABP 0.4%
Ejection fraction (mean) 43.8%
Diabetes 31.4%
Body mass index 30 kg/m2 33.4%
Renal failure (nondialysis) 4.7%
NYHA functional class IV 51.4%
Hypertension 79.5%
Dyslipidemia 80.9%
Current tobacco use 29.7%
Family history of CAD 74.8%
CABG  coronary artery bypass grafting; CAD  coronary artery disea
PCI  percutaneous coronary intervention.
able 2 Procedural Charactertistics
Previous CABG,
Yes (n  4,211)
Previous CABG,
No (n  69,001) p Value
luoroscopy time, mean (min) 20.2 13.6 0.0001
ontrast volume, mean (ml) 243.8 213.6 0.0001
CC/AHA lesion risk type C 66.4% 59.0% 0.0001
esion length, mean (mm) 21.2 19.8 0.0924
eak troponin, mean (ng/ml) 47.9 64.8 0.0001
eak CK-MB, mean (U/dl) 154.9 195.3 0.0001CC/AHA American College of Cardiology/American Heart Association; CABG coronary artery
ypass grafting; CK  creatine kinase.cantly longer DTB times if they were transferred from a
eferring hospital (1,652 min vs. 1,466 min; p  0.06).
ssociation of previous CABG with in-hospital mortality.
uring the study period, 3,623 (5.2%) patients undergoing
rimary PCI for STEMI experienced an in-hospital death.
he majority (80.9%) of in-hospital deaths were attributable
o a cardiac cause. Previous CABG surgery was associated
p<0.0001
P
at
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nt
s
50%
40%
30%
20%
10%
 0%
≤ 90 > 90 and < 120 ≥ 120
igure 1 Distribution Differences in DTB Time
etween Patients With and Without Previous CABG
he p value is representative of differences in time distribution between coro-
ary artery bypass grafting (CABG) and non-CABG patient groups. Solid bars
prior CABG, yes (median door-to-balloon [DTB] time  113 min); open bars
prior CABG, no (median DTB time  98 min).
Previous CABG,
No (n  69,001) p Value
61.0 0.0001
9.2% 0.0001
3.9% 0.0001
0.3% 0.0001
6.5% 0.0001
5.8% 0.0001
11.8% 0.0001
16.4% 0.0001
0.4% 0.54
46.2% 0.0001
20.6% 0.0001
34.8% 0.098
2.3% 0.0001
52.1% 0.17
58.3% 0.0001
55.4% 0.0001
44.5% 0.0001
76.3% 0.029
P  intra-aortic balloon pump; NYHA  New York Heart Association;G,
11)DTB Time (minutes)
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Association of Previous CABG Surgery With DTB Time November 11, 2008:1665–70ith significantly greater unadjusted in-hospital mortality
odds ratio [OR]: 1.54, 95% confidence interval [CI]: 1.35
o 1.75; p  0.001). Among patients with a history of
revious CABG surgery, prolonged DTB time was associ-
ted with significantly greater unadjusted in-hospital mor-
ality regardless of whether the culprit lesion was within a
ative vessel or a graft vessel (Fig. 3). When stratified by
ulprit lesion location, however, there was no significant
ifference in in-hospital mortality between subgroups
7.79% in the native vessel culprit group vs. 9.07% in the
raft vessel culprit group; p  0.23).
When in-hospital mortality was adjusted for differences
n baseline patient characteristics, previous CABG surgery
as no longer significantly associated with increased in-
Transfer Patients
90%
80%
70%
60%
50%
40%
30%
20%
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0%
≤ 90 ≥ 120> 90 and < 120
60%
50%
40%
30%
20%
10%
 0%
≤ 90 ≥ 120> 90 and < 120
Non-Transfer Patients
p<0.0001
p<0.0001
Prior CABG - Yes (n = 1016)
Prior CABG - No (n = 19,055)
Prior CABG - Yes (n = 3195)
Prior CABG - No (n = 49,946)
DTB Time (minutes)
DTB Time (minutes)
P
at
ie
nt
s
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s
igure 2 Distribution Differences in
TB Time Between Transfer and Nontransfer Patients
he p values are representative of differences in time distribution
etween CABG and non-CABG patient groups. Abbreviations as in Figure 1.ospital mortality (OR: 1.07, 95% CI: 0.91 to 1.25; p .41). When in-hospital mortality was adjusted for differ-
nces in both baseline patient characteristics and DTB time,
revious CABG surgery was not significantly associated
ith increased in-hospital mortality (OR: 1.04, 95% CI:
.89 to 1.22; p  0.64) (Fig. 4). Further adjustment for the
nteraction between a previous history of CABG surgery
nd DTB time was not significant (OR: 1.14, 95% CI: 0.86
o 1.50; p  0.37 for DTB time 90 min, OR: 0.76, 95%
I: 0.54 to 1.08; p  0.12 for DTB time between 90 and
20 min, and OR: 1.12, 95% CI: 0.91 to 1.37, p  0.28 for
TB time 120 min).
iscussion
revious CABG surgery was associated with a significantly
onger median DTB time in patients undergoing primary
CI for STEMI compared with patients without a history
f CABG surgery. Similarly, a significantly greater propor-
igure 3 In-Hospital Mortality Based on Type of
nfarct-Related Artery Among Patients With Previous CABG
he p values are representative of differences in time distribution between
atient groups. Solid bars  DTB time 90 min; open bars  DTB time 90
nd 120 min; blue bars  120 min. Abbreviations as in Figure 1.
Odds Ratio
1.54
1.07
1.04
1.35 - 1.75
0.91 - 1.25
0.89 - 1.22
95% Confidence
Interval
Unadjusted
Adjusted
Adjusted
(Baseline characteristics
(Baseline characteristics)
+ DTB time)
igure 4 Association of Previous CABG With In-Hospital Mortality
dds ratios and 95% confidence intervals
re shown. Abbreviations as in Figure 1.0 1 2
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November 11, 2008:1665–70 Association of Previous CABG Surgery With DTB Timeion of patients with previous CABG surgery had DTB
imes 90 min. These findings were consistent among
atients who presented to a primary PCI facility and among
atients who were transferred for primary PCI. The longer
TB times among patients with previous CABG surgery
id not, however, translate into greater risk-adjusted in-
ospital mortality.
The ACC/AHA guidelines contain a Level I recommen-
ation for achieving a DTB time of 90 min or less for
TEMI patients treated with primary PCI. These guide-
ines are based in part on several studies demonstrating that
atient outcomes are directly correlated to DTB time (4–6).
ecause DTB time has evolved into a reportable perfor-
ance measure for hospitals nationwide, there has been
ntense focus placed nationally on strategies to reduce DTB
ime in patients undergoing primary PCI for STEMI (8).
or example, the D2B: An Alliance for Quality is a national
nitiative established by the ACC aimed at reducing DTB
imes in hospitals in the U.S. in which PCIs are performed.
In clinical practice, however, various logistical and clinical
ssues often present considerable challenges in achieving
imely reperfusion (9). As a result, only a minority of
atients with STEMI are treated within the recommended
oal reperfusion time of 90 min or less (3). The authors of
everal observational studies have suggested that one factor
ubstantially delaying DTB time in primary PCI for
TEMI is a previous history of CABG surgery (10,11). In
cross-sectional analysis of data from patients enrolled in
he National Registry of Myocardial Infarction, 56.9% of
atients with a history of previous CABG surgery had a
TB time120 min, with a median DTB time of 129 min
ompared with an overall median DTB time of 111 min
p  0.0001) (10,12). These registry studies, however, did
ot comment on potential reasons for the delayed DTB
ime in the subgroup of patients with previous CABG
urgery, nor did they investigate the outcomes of such
atients.
In our analysis of the NCDR, we demonstrated that a
istory of previous CABG surgery is associated with a
rolonged DTB time. In addition, the differences in DTB
ime between patients with previous CABG surgery and
hose without previous CABG surgery persist regardless of
he need for patient transfer to a referral facility equipped to
erform primary PCI. Furthermore, DTB times were sim-
lar among patients with previous CABG with respect to the
ocation of the culprit vessel (i.e., native vessel vs. graft
essel). These data confirm that there likely exist clinical
actors inherent to STEMI patients with previous CABG
urgery that lead to quantifiable delays in revascularization.
lthough it is difficult to decisively determine causes forhese delays based on clinical information provided to the nCDR, the available data are hypothesis-generating none-
heless. For example, patients with previous CABG surgery
xperienced significantly longer fluoroscopy times and re-
uired greater contrast volumes. This finding is expected
iven the need to evaluate both native and graft vessels
uring diagnostic angiography. The added need to evaluate
raft vessels may significantly prolong DTB time in and of
tself, especially in cases where detailed graft anatomy is not
nown. Additionally, patients with previous CABG surgery
lso demonstrated a greater frequency of high-risk (i.e.,
CC/AHA type C) lesions compared with patients without
revious CABG surgery, suggesting that the nature of the
ulprit lesion may play a significant role in prolonging DTB
ime. Further studies are needed to better decipher the
easons (clinical, technical, and so on) underlying prolonged
TB time in patients with previous CABG surgery.
The clinical benefit of primary PCI in STEMI is closely
ied to DTB time (4,5,13). Although patients with a
revious CABG surgery also had prolonged DTB times
ompared with their non-CABG surgery counterparts, a
revious history of CABG surgery was not associated with
n increase in risk-adjusted in-hospital mortality. These
esults suggest that in this unique subset of patients, a
rolonged DTB time does not correlate to an increase in
isk-adjusted in-hospital mortality.
The reason for the disparity between our findings and the
ata reported in previous studies relating mortality to
rolonged DTB time, however, remains an intriguing find-
ng with an unclear explanation. One possible explanation
or this finding is that although significantly prolonged
TB times were observed in patients with previous CABG
urgery, the presence of either preserved native coronary
rtery or collateral artery flow to the at-risk myocardium
ay offer enough coronary perfusion to minimize the extent
f infarcted myocardium. Another possible explanation for
he finding is that CABG conduits may supply quantifiably
ess myocardium per graft than a native coronary artery,
hereby resulting in less myocardial damage after occlusion.
hese hypotheses are partially supported by the data illus-
rating that patients with previous CABG surgery had
ignificantly lower peak troponin and creatine kinase-
yocardial band values compared with patients without
revious CABG surgery. Further investigation into this
nexpected finding as well as evaluation with longer-term
utcomes, however, is clearly needed.
A potentially significant implication of our study’s results
evolves around its impact on hospital performance mea-
urement. Designated as a Centers for Medicare and Med-
caid Services and the Joint Commission on Accreditation
f Healthcare Organizations Core Measure, DTB time is
ow directly tied to the public reporting of hospital perfor-
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Association of Previous CABG Surgery With DTB Time November 11, 2008:1665–70ance, Centers of Excellence designations, and Pay-for-
erformance initiatives. The DTB time performance mea-
urement, however, is neither risk-adjusted nor stratified by
history of previous CABG surgery. As a result, hospitals
ith an above-average case mix of patients with previous
ABG surgery may ultimately report an overall worse
erformance in the DTB time Core Measure, which may
egatively impact both their public status as a health care
rovider as well as their potential for financial reimburse-
ent. On the basis of our findings that a prolonged DTB
oes not correlate to an increase in risk-adjusted in-hospital
ortality in patients with previous CABG surgery, consid-
ration may need to be given to risk adjustment of perfor-
ance measures and/or stratified reporting of the DTB time
ore Measure by patient status (i.e., previous CABG surgery).
tudy limitations. Our analysis of the impact of previous
ABG surgery on DTB time and in-hospital outcomes has
everal potential limitations. First, this is a post-hoc analysis
f a large general PCI registry and includes only facilities
oluntarily participating in the CathPCI registry of the
CDR. As a result, the results may not be generalizable,
lthough it reflects a national sample of 638 facilities, and
here is no a priori reason to assume that the results would
ot be applicable to hospitals that do not report to NCDR.
econd, the choice of variables used for determining risk-
djusted in-hospital mortality, although thorough, are by no
eans all-inclusive and may not account for the presence of
pecific unmeasured confounders.
onclusions
n this analysis of the NCDR, a history of CABG surgery
as associated with significantly prolonged DTB time in
atients undergoing primary PCI for STEMI. This finding
id not translate into a greater in-hospital risk-adjusted
ortality, yet it may substantially impact the performance
easurement for a given hospital depending on the case
ix. Thus, the results of this study may have implications
or the way that DTB performance measures are reported.
eprint requests and correspondence: Dr. John C. Messenger,
niversity of Colorado Denver–Anschutz Medical Campus, 12401
ast 17th Avenue, Campus Mail Stop B-132, P.O. Box 6511,
urora, Colorado 80045. E-mail: John.Messenger@UCHSC.edu.
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